Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Schacker

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in ThailandMichelle Chintanaphol, Carlo Sacdalan, Suthat Chottanapund, et al.
Cell Reports. Medicine|June 4, 2026
HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivoRoss T Cromarty, Julien A Clain, Yvette Soigner, et al.
Open Forum Infectious Diseases|February 15, 2020
Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical TrialJason V Baker, Julian Wolfson, Tess Peterson, et al.
Cell Reports|October 5, 2021
High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccinesKathryn A Pape, Thamotharampillai Dileepan, Amanda J Kabage, et al.
Journal of Virology|November 10, 2017
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral TreatmentAmy L Ellis-Connell, Alexis J Balgeman, Katie R Zarbock, et al.
The Journal of Infectious Diseases|January 11, 2024
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV InfectionJeffrey S Miller, Joshua Rhein, Zachary B Davis, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Multi-omics links microbial dysbiosis, systemic inflammation and metabolomic disruptions to SNAE risk in treated HIVChristopher M Basting, Jodi Anderson, Kevin Escandón, et al.
Pathogens & Immunity|July 19, 2016
Defining HIV and SIV Reservoirs in Lymphoid TissuesClaire Deleage, Stephen W Wietgrefe, Gregory Del Prete, et al.
Clinical Biochemistry|February 4, 2021
Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISAStefani N Thomas, Ghaith Altawallbeh, Christopher P Zaun, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissuesCourtney V Fletcher, Kathryn Staskus, Stephen W Wietgrefe, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2018
Brief Report: Safety and Tolerability of Inguinal Lymph Node Biopsy in Individuals With Acute HIV Infection in ThailandMichelle Chintanaphol, Carlo Sacdalan, Suthat Chottanapund, et al.
Cell Reports. Medicine|June 4, 2026
HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivoRoss T Cromarty, Julien A Clain, Yvette Soigner, et al.
Open Forum Infectious Diseases|February 15, 2020
Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical TrialJason V Baker, Julian Wolfson, Tess Peterson, et al.
Cell Reports|October 5, 2021
High-affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccinesKathryn A Pape, Thamotharampillai Dileepan, Amanda J Kabage, et al.
Journal of Virology|November 10, 2017
ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral TreatmentAmy L Ellis-Connell, Alexis J Balgeman, Katie R Zarbock, et al.
The Journal of Infectious Diseases|January 11, 2024
Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV InfectionJeffrey S Miller, Joshua Rhein, Zachary B Davis, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Multi-omics links microbial dysbiosis, systemic inflammation and metabolomic disruptions to SNAE risk in treated HIVChristopher M Basting, Jodi Anderson, Kevin Escandón, et al.
Pathogens & Immunity|July 19, 2016
Defining HIV and SIV Reservoirs in Lymphoid TissuesClaire Deleage, Stephen W Wietgrefe, Gregory Del Prete, et al.
Clinical Biochemistry|February 4, 2021
Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISAStefani N Thomas, Ghaith Altawallbeh, Christopher P Zaun, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissuesCourtney V Fletcher, Kathryn Staskus, Stephen W Wietgrefe, et al.
Pageof 9